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Coronary angioplasty, once an investigational alternative to
bypass urgery (l-.5), is now a widely accepted therapy for 
coronary artery disease. Because of the progressive nature 
of coronary artery disease, patients i itially treated with one 
approach are often subsequently treated with ano er. Ther- 
apeutic choices among medical, angioplasty and surgical 
therapy must take into account the long-term i plications of
these different techniques. 
In May 1977, the first human (intraoperative) coronary 
balloon angioplasty procedure was performed in San Fran- 
cisco (1). In September 1977, the first percutaneous trans- 
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luminal coronary angioplasty was performed inZurich (2,3) 
and 6 months later it was introduced to the United States 
(4,5). This study presents he long-term outcome of this early 
angioplasty experience in North America. 
Study patients. All patients (n = 217) undergoing at-
tempted coronary angioplasty be ween March 1978 and July 
1981 and followed up at the San Francisco Heart Institute 
,are included in this study. These patients were followed up 
allel as part of the initial 
Institute Coronary Angioplasty (PTCA) Registry 
to 1981). Clinical information and the details of each 
angioplasty were obtained from an ongoin 
data base maintained by the San Francisco 
Follow-up data were obtained from medical records as well 
as by contacting the patients and their eferring physicians at
6 month intervals. 
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‘Fable 1. Clinical Profile of 217 Patients Undergoing Coronary 
Angioplasty Between 1978 and 1981 
Patients 
(no.) % 
Male 167 77 
Female 
Hypertension 
Diabetes 
Sioking 
Prior MI 
LVEF 
<45% 
>45% 
Angina class* 
1 
2 
3 
4 
SVD 
DVD 
TVD 
SO 23 
81 38 
18 9 
65 31 
150 69 
45 21 
13 6 
87 94 
0 0 
80 39 
117 57 
8 4 
188 87 
27 12 
2 I 
*Canadian Cardiovascular Society classification. DVD = double vessel 
disease: LVEF = left ventricular ejection fraction: MI = myocardial nfarc- 
tion: SVD = single vessel disease: TVD = triple vessel disease. 
Patient profile. The 217 patients who underwent coro- 
nary angioplasty during the study period had a mean age of 
53 + 9 years. All patients were symptomatic, with 61% in 
Canadian Cardiovascular Society class 3 or 4 (6). Single 
vessel disease was present in 87% and multivessel disease in 
13%. A treadmill exercise test was performed in 207 patients 
(95%) and planar thallium exercise testing in 197 (91%). with 
objective vidence of ischemia in 205 patients (94.5%). 
Further clinical data are presented in Table 1. 
Angioplasty protocol. During the period of this study 
(1978 to 1981), coronary angioplasty was considered an 
(investigational) option only for patients in whom coronary 
bypass urgery was planned because of relatively refractory 
symptoms ora large amount of myocardium at risk, or both. 
Coronary angioplasty was attempted only if there was ~70% 
reduction i vessel diameter dueto a lesion that was proxi- 
mal, discrete, concentric, noncalcified and did not involve a 
major arterial branch. At the beginning of this period, left 
mainstem stenosis was not considered a contraindication of 
angioplasty. Subsequently, adverse late events in “unpro- 
tected” cases, notably sudden death, changed this policy 
(3,7). Single vessel angioplasty was the rule: multivessel 
angioplasty was rarely performed. 
During this period, abrupt closure of an artery after 
angioplasty was treated by immediate surgery, without an 
attempt to reopen the artery with an angioplasty catheter. 
Patients who did not have a significant improvement in 
luminal diameter after angioplasty were referred for elective 
bypass urgery. Late restenosis was an indication for elec- 
tive surgery from 1978 to 1980 and repeat angioplasty for 
recurrence was only attempted toward the end of 1981. 
Angloplasty echnique. Techniques used during this pe- 
riod were those described by Gruentzig et al. (3,5). Equip- 
ment consisted of 9.4F, solid Teflon femoral guiding cathe- 
ters. In 1980, multilayered guiding.catheters were introduced 
and permitted more facile cannulation f the coronary arter- 
ies. Femoral sheaths for guiding catheter insertion were not 
available until 1980. Balloon dilation catheters were rela- 
tively large profile (1.2 to 1.3 m deflated balloon diameter), 
nonsteerable, no wire or fixed ire devices. Dilation cathe- 
ter shafts were made of polyvinylchloride, as were the 
balloons themselves. The latter were initially 12 mm long 
(later 25 mm) and 2.0, 2.5, 3.0 and 3.7 mm in (inflated) 
diameter, Recommended maximal inflation pressure was 6 
atm. 
In this series, balloons were inflated to a mean of 6 atm 
for an average of17 s, with 3.8 inflations per lesion. Neparin, 
dextran and nitroglycerin were administered during the 
procedure. At the end of the procedure, protamine was 
administered. Aspirin and dipyridamole were initiated be- 
fore angioplasty and continued for 6 months. Calcium chan- 
nel blockers were not initially available (in the United States) 
ere subsequently (1980 to 1981) used. 
orphology profile. Coronary angioplasty was per- 
formed in a single coronary artery in 215 patients; 2 patients 
had double vessel angioplasty. Arteries dilated were the left 
anterior descending in 152 patients (70%), right coronary in 
47 (220/o), left circumflex in 11 (5%), diagonal branch in 2 
(I%), acute marginal branch in 1 (0.5%) saphenous graft in 
1 (0.5%) and left main stem in5 (2%). 
Definitions. The following definitions were used: 
Procedural success: a >20% reduction of the initial 
percent diameter stenosis and no major cardiac event, as 
originally proposed by Gruentzig et al. (3). Currently, a 
stricter definition of success i utilized at this institution (8). 
Vnsuccessfid, uncomplicated procedure: one in which 
success was not obtained but there were no complications 
(that is, major cardiac events). 
Major cardiac event: occurrence of one (or more) of the 
following mutually nonexclusive events: need for coronary 
artery bypass urgery, Q wave myocardial infarction or 
death. 
Myocurdiul infarction: a coronary ischemic event asso- 
ciated with abnormally elevated cardiac enzymes, lectro- 
cardiographic (ECG) changes consistent with myocardial 
infarction and a clinical diagnosis of myocardial nfarction, 
Q wave myocardial infnrction: a myocardial infarction 
with the development of new ECG Q waves, 
Initial outcome. All patients had one of three clinical 
outcomes: procedural success, unsuccessful and uncompli- 
cated or complicated by a major cardiac event. 
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1. Initial results in 217 pat’ 
between Wdand 1981. See 
terms. EmCABG = emergen 
wave myocardial infarction. 
undergoing coronary angio- 
Surgical success: survival after corona 
performed electively within 2 months afte 
but uncomplicated angioplasty attempt. 
s surgery 
uccessful 
Restenosis: a loss of ~50% of the gain in I 
eter at the site of initially successful aagioplas 
Revascularization: coronary angioplasty orcoronary by- 
pa urgery. 
tisticall analyses. Continuous variables are expressed 
as mean values k S . Student’s t tests were pe 
determine significant differences between 
square analyses or Fisher’s exact ests we 
categoric variables. Differences were accepted as signiificant 
at a p value .05. Life table analyses were p rformed by 
the Kaplan- ter method (IO), and differences in survival 
rates were compared using the Lee-Desu 
Analyses were performed on a MicroVax I1 c 
SPSSX and BMDP statistical software. 
Early Outcome 
utcome of the entire co ort. Angioplasty was clinically 
successful in 143 (66%) of the 217 patients (Fig. 1). There 
was >20% diameter stenosis improvement i  148 (68%) of 
219 vessels; the mean percent diameter s nosis was reduced 
from 87 k 9% to 35 -C 10%. Angioplasty was unsuccessful 
but uncomplicated in 65 patients (30%) and complicated by a 
major cardiac event in 9 (4%). The average hospital stay was 
5.7 days. 
Major cardiac events complicating angioplasty consisted 
of emergency bypass urgery in eight patients (4%) and 
death in one (0.5%). Emergency surgery was necessary 
because of a clinical diagnosis of vessel closure within hours 
Angioplasty Surgery 
Unsuccessful 
Success Uncomplicated Success p Value 
No. of patients 143 65 56 
Age (yr) 5? 54 54 NS 
Male 78%, 78% 77% NS 
22% 22Qr 23% NS 
36% 40% 38% NS 
Diabetes 7% 12% 13% NS 
Nypercholesterolemia 32% 26% 35% NS 
68% 62% 66% NS 
21% 20% 20% NS 
45% 5% 6% 7% NS 
Angina class 3 or 4* 52% 68% 68% NS 
SVD 88% 83% 80% NS 
MVD 12% 17% 20% NS 
DS 
Pre-PTCA 87% 90% 91% NS 
Post-FTCA 35% 86% 87% <0.01+ 
*Canadian Cardiovascular Society classification. t35% versus 86% or 
87%. DS = diameter stenosis; MVD = multivessel disease: P’KA = coronary 
angioplasty: other abbreviations as in Table I. 
of the procedure in all patients. In only one case was vessel 
closure confirmed angiographically nd an attempt 
reopen the vessel. No patient having emergency surgery 
died, although four patients (2%) had a Q wave myocardial 
infarction. A single death (0.5%) occurred in 1979 ina patient 
who underwent elective bypass surgery 2 days after angio- 
plasty that, as assessed in retrospect, was complicated bya 
small non-Q wave myocardial infarction. This patient had a 
cardiac arrest during anesthesia induction and died 2 days 
postoperatively from disseminated intravascular coagulopa- 
thy. 
Suecessfuul versus unsuccessful, u~compti~te~ augi~~]~Uy. 
Multiple variables were analyzed to define dieerences b -
tween patients inwhom coronary angioplasty was successful 
and those in whom it was unsuccessful but uncomplicated. 
No significant differences b tween the two groups were 
found with regard to commonly recognized prognostic fac- 
tors (Table 2). 
A higher proportion of patients with a successful as 
compared with an unsuccessful procedure had angioplasty of 
the left anterior descending coronary artery (73% versus 
65%, p < 0.05). Patients with an unsuccessful procedure 
were more likely to have attempted angioplasty of the right 
coronary artery (29% versus 20%, p < 0.05). The reasons for 
this lack of success were inability to 1) cannulate the 
coronary artery with a guiding catheter in I4 patients, 2) 
cross the lesion with the balloon catheter in37, or 3) increase 
luminal diameter >20% after balloon inflation in 14. 
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Figure 2. Late outcome in 213 patients after attempted coronary 
angioplasty. Life table shows freedom from myocardial infarction 
(MI), coronary bypass surgery (CABG) and death. 
Late Outcome 
Outcome ofentire cohort. Follow-up data were obtained 
for 213 (98%) of 217 patients. At a mean of 9 2 1 years, the 
incidence of late myocardial infarction was 9% and of 
cardiac death was 7%; 84% of patients were free of angina 
(Table 3). The actuarial survival rate was 98% at 5 years, 
93% at 9years and 92% at 10 years. Freedom from myocar- 
dial infarction, (repeat) surgery or death was 76% at 10 years 
(Fig. 2). 
Outcome after successful aogioplasty. Follow-up data 
were obtained for 140 (98%) of 143 patients at a mean of 9 r 
1 years (Table 3). Planar thallium scintigraphy was repeated 
shortly after discharge (mean 3months) in 89 patients with a 
previously positive study; 67(75%) had a negative r sult for 
ischemia. Angiographic follow-up data were obtained at this 
institution i  108 patients at a mean of 16 + 22 months. 
Restenosis was documented in 40 patients and a new signif- 
icant lesion (>60% reduction i  vessel diameter) in 9.
At follow-up study, a subsequent revascularization pro- 
cedure was performed in 59 patients (42%): repeat angio- 
plasty in 36 (26%), bypass urgery in 21 (15%) and both 
procedures in 2 (1%). Repeat revascularization was ecessi- 
tated by restenosis n 74%, disease progression i a new 
location in 14% and (what would currently be considered) an 
inadequate initial angioplasty result in 12%. As defined 
earlier, aprocedural success during this period was a >2Q% 
reduction i  stenosis diameter (3).In no patient was repeat 
angioplasty complicated by Q wave infarction, emergency 
surgery or death. Actuarial survival was 98% at 5 years, 93% 
at 9 years and at 92% at 10 years. Freedom from myocardial 
infarction, elective bypass urgery or cardiac death was 86% 
at 5 years, 76% at 9 years and 76% at 10 years. 
Outcome atIer unsuccessful, ncomplicated angioplasty. 
Follow-up data were obtained for 64 (9%) of 65 patients at 
a mean of 9 -e 1 years after unsuccessful, ncomplicated 
angioplasty (Table 3). 
Elective bypass surgery after unsuccessful, uncomplicat 
ungioplasty. Of the 65 patients with unsuccessful but un- 
complicated angioplasty, 58 underwent elective coronary 
bypass surgery within 2 months of the angioplasty attempt; 
there were 56 survivors and 2 perioperative d aths. Follow- 
up data at a mean of 9 + 1 years were obtained for all 56 
surgical survivors (Table 4). Further evascularization was 
necessary in 10 patients (18%): angioplasty in 6 (1 I%), 
reoperation i  3 (5%) and both procedures in I (2%) (Table 
5). 
Comparison f successful sngioplasty ad successful sur- 
gery. The 140 patients with successful an:ioplasty were 
compared with the 56 patients with suo:essful elective 
bypass urgery. There were no statistically significant differ- 
ences between these two groups with regard to numerous 
Table 3. Late Outcome V rsus Initial Clinical Outcome of the Angioplasty Procedure (9 + 1 years) 
in 213 Patients 
Initial Outcome 
Unsuccessful Unsuccessful 
Entire Cohort Success Uncomplicated Complicated* 
No. (%) No. (%) No. (%) No. (%I 
No. of patients 213 100 140 loo 64 100 9 100 
Survival 194 91 130 9? 57 89 I 78 
Mortality 
Total 19 9 IO 7 7 II 2 22 
Cardiac 14 7 7 5 5 8 2 22 
Noncardiac 5 2 3 2 2 3 0 0 
CABG 84 39 23 I6 60 94 I II 
Late MI I9 9 I2 9 6 9 I II 
Late PTCA 45 21 38 27 I II 0 0 
Angina free 178 84 II9 85 52 81 7 78 
Ml, CABG or cardiac death % 45 33 24 60 94 3 33 
*Complicated by a major cardiac event. See Methods section for definitions of terms. CABG = coronary bypass 
surgery; other abbreviations as in Tables I and 2. 
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~o~~arjso~ of Late Olatcome After Succe 
asty and Successful E ective Surgery in 200 
FTCA Success 
NO. % 
CABG Success 
-- 
No. % p Value 
Total 
Survival 
Mortality 
Total 
Cardiac 
Noncardiac 
Late MI 
Angina free 
cardiac death 
Abbreviations as in Tables I and 3. 
56 I 
53 95 
3 5 NS 
3 5 NS 
0 0 NS 
5 9 NS 
48 86 NS 
14 25 NS 
- 
NS 
clinical and rnor~b~~~g 
pleteness off~l~5w-~~, 
infarction elec:ive su 
outcome at 9 years for the angiopiasty and surgical groups 
was similar: :urvival was 93% versBs 95% (p = NS) and 
freedom from death or infarction was 89% versus 87.5% (p = 
NS), re y (Fig. 3). 
The y of repeat rev~sci4~~riz~tion i these two 
groups is presented in Figure 4. §ubseq~cnt revasculariza- 
tion was required more often after successful angi 
than after successful surgery (42% versus IS%, p C 
At a mean of 9 years, the likelihood of a patient with an 
initially successful angioplasty procedure undergoing 
quent bypass surgery was slightly higher than the like 
of crossover f om surgery to angioplasty (16% versus 12.5%. 
p = NS). However, crossover in the angioplasty g 
occurred earlier (21 4 29 versus 76 + 29 months, p< 0 
(Table Most patients undergoing surgery after initially 
succes I amgiopiasty did so within 2 years; in contrast, 
Figure 3. Late outcome in 140 patients after successful coronary 
angioplasty (PTCA) and 56 patients after successful coronary artery 
bypass surgery (CABG) (performed electively within 2 months of an 
unsuccessful but uncomplicated angioplasty attempt). Life tables 
compare the incidence of survival (A) and freedom from death or 
myocardial infarction (Ml), or both (I%). 
most patients crossing from surgery to angioplasty did so 
much later. 
My. Follow-up data t 
a mean of 9 + 1 years were obta d for all eight patients 
whose initial angioplasty was c licated by emergency 
Table 5. Comparison f Subsequent Revascularization Procedures After Successful Angioplasty 
and Successful E ective Surgery in 200 Patients 
PTCA Success CABG Success 
No. 1%) No. (%‘c) p Value 
Totdt 140 IO0 56 100 - 
Late FTCA 38 27 I 12.5 0.05 
Late CABG 23 16 4 7 0.09 
Late PTCA or CABC 59* 42 lot 18 0.001 
Crossover 23 16 7 12.5 0.12 
Time to late PICA (mo.) 25 -c 35 76 k 29 0.001 
Time to late CABG (mo.) 21 2 29 30 !I 44 0.11 
Time to late PTCA or CABG (mo.) 25 + 33 62 t 37 0.001 
Time to crossover (mo.) 21 229 76 + 29 O.OOI 
*Two patients had both procedures; tone patient had both procedures. Crossover = successful angioplasty 
followed by !ate bypass surgery or successful surgery followed by late angioplasty. Abbreviations as in Tables 1 
and 3. 
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llME I 
surgery (and the single arly death). Late outcome isdetailed 
in Table 3. 
Discussion 
hng=term follow-up after angioplasty. This study pre- 
sents the outcome of patients who underwent coronary 
angioplasty during the early years in the development of this 
procedure. The longest previously reported fellow-up eriod 
consists of the initial Zurich experience (1977 to 1980) (12) in 
which the actuarial survival rate at 6 years after successful 
angioplasty was 93%. A report from Emory University (13) 
found a 5 year survival rate of 97% and others (14-17) 
reported similar esults with shorter-term follow-up data. 
Our study extends these results, with an actuarial survival 
rate of 98% at 5 years, 93% at 9years and 92% at 10 years. 
Late outcome at 10 years was characterized by freedom 
from cardiac death, infarction or bypass surgery in 76%. 
Because the mortality rate in patients with single vessel 
disease is low, it is difficult o assess a potential benefit oi’ 
angioplasty in terms of survival. The survival rate at 5 years 
has been reported (18-20) to be 90% to 97% in patients with 
medically treated single vessel disease. The 5 year survival 
rate after successful angioplasty documented here (98.5%) 
compares favorably. 
Cha@ng procedure, definitions and indications. Current 
techniques and criteria of patient selection for coronary 
angioplasty have volved greatly from those of a. decade ago. 
The results reported here were compared with a review of 
Figure 4. Late revascularization fter suc- 
cessful angioplascy and after successful 
surgery (performed electively within 2 
months of an unsuccessful, ncomplicated 
angioplasty attempt). Life tables show the 
incidence of late repeat revascularization 
(surgery or angioplasty) (A), late angio- 
plasty (IS), late surgery (C) and treatment 
crossover (surgery to angioplasty or angio- 
plasty to surgery (D). Abbreviations as in 
Figure 3. 
123455782Xbll 
TIME (V 
the most recent 1,500 cases of simple single vessel coronary 
angioplasty at our institution. Procedural success increased 
from 66% (reported here) to 93% and unsuccessful but 
uncomplicated procedures decreased from 30% to 4%; the 
incidence rate of major cardiac events decreased from 4% to 
3%. 
A comparison of coronary angioplasty data from the 
National Heart, Lung, and Blood Institute PTCA Registry 
during 1977 to 1981 versus 1985 to 1986 revealed similar 
changing patterns and results of single vessel angioplasty 
(21-23). Procedural success increased from 64% to 84%, 
whereas major cardiac events decreased from 9% to 5%, 
emergency surgery from 6% to 3%, nonfatal infarction from 
5% to 3.5% and mortality rate from 1.3% to 0.2%. Notably, 
there was a sharp decline in patients undergoing elective 
bypass urgery during the same admission after an unsuc- 
cessful angioplasty attempt (19.5% to 1.7%). There was also 
an increased use of repeat angioplasty (rather than surgery) 
for restenosis ordisease progression. 
Y.!r:r current approach to postangioplasry vessel closure 
includes repeat dilation or medical therapy (for example, 
thrombolysis), or both, and other measures that are often 
successful. At the time of this study, vessel closure after 
angioplasty “mandated” immediate surgery. Retrospective 
review of the eight patients who had emergency surgery 
showed that an attempt to reopen the artery with emergency 
repeat angioplasty would have been made in all. 
The definition of success used at the time of this study 
(>20% increase inluminzl diameter) was originally proposed 
a >35% reductio 
likely to undergo em 
or elective 
available, an incidence consistent with that in other eports 
(9,24,3(l). Patients with ret symptoms or a positive 
stress test were more likely ergo a~giogra~~y, Thus. 
this restenosis rate would t overestimate the risk of 
recurrence for the group as a whole (bias of ascertainment). 
Restenosis rarely occurs >6 mouths after a~g~Q~~asty 
(9.31,32). However, as evideo~ed by the freq~~~~ 
subsequent revas~u~ar~zatio~, there may be disease progres- 
sion. During this early period, recurrence ofstenosis was an 
indi~~oa for elective surgery; most pat~eats wit
currently undergo repeat a~g~oplasty with a high ~~~~~i~ood 
of success (8,28,29). 
Compa~~s~~ of successful ang 
cry. A randomized trial compar outcome after coronary 
angioplasty and bypass urgery is not yet available, although 
several trials are in progress inthe United States and Europe 
(33) in patients with multivessel disease. There is justifica- 
tion for comparing the long-term outcome of patients after 
successful angiopiasty with that of a similar group of patients 
who had successful bypass urgery. fn this study, comp~- 
son of patients who had asuccessful angioplasty and those 
who had an unsuccessful but uncomplicated angioplasty 
followed by elective surgery (as planned before the angio- 
plasty attempt) showed no significant differences with re- 
spect o prognostic variables, survival or incidence of myo- 
cardial infarction. 
Also daring this early period, ansaccessfid arlgioplasty 
was usually the malt of technical factors unrelated to the 
sever@ of disease; angioplasty equipment was undeveloped 
and experience limited. Common reasons for failure during 
this era are rarely ncountered today (for example, failure to 
cannulate the coronary ostium with a guidi~ catheter, 
retort a s~rn~~ar experience (21). 
ss surgery soon 
6% of patients in whom angioplasty was successfu’uil even- 
ass surgery were associated 
with s~rnj~ar rates of survival i~far~t~o~ d ing hong-ter 
follow-up eva~~at~o~. 
asty was associated 
t revascularization. 
This was mainly due to recurrence and need for repeat 
angioplasty. Our results of late revasc~~ar~zatio~ after suc- 
cessful a~gio~lasty (surgery in 16% and repeat aagio~~sty in 
2~% at 9 years) concur h a report from Emory university 
(13) in wb~c~ 13.5% of ients had bypass urgery and 26% 
required repeat ang~o~ y 5 years after the ~n~tial success- 
ful a~gioplasty. 
fn our study, the likelihood of a patient with successfuul 
angioplasty subsequently undergoing bypass urgery was 
only slightly higher than that of a patient with successful 
bypass urgery undergoing angioplasty. Treatment cross- 
over from angioplasty osurgery and from surgery to angio- 
plasty occurred with similar frequency, but the time of 
crossover differed. Patients undergoing angioplasty initially 
crossed over earlier than did patients having surgery ini- 
tially. This may reflect the fact that restenosis tends to occur 
earlier (9,31,32) than disease progression i  vein grafts 
(34.35). Future studies of angioplasty and coronary bypass 
surgery should obtain long-term follow-up data to a&- 
quately assess the etTects of restenosis, graft failure and 
disease progression. Relatively short-term follow-up data 
from the angioplasty-bypass surgery trials now in progress 
may detect angioplasty restenosis. but would be too early to 
completely assess the incidence of graft failure and its 
sequelae. 
~mproverner,~~ in both a~gioplasty and surgical teeh- 
past decade may have reduced the incidence 
ture and subsequent crossover. A~g~oplasty 
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remains associated with a signi~~ant recurrence rate, but 
may be repeated atrelatively ow risk for either estenosis or
disease progression (28,29). Improvements in surgical tech- 
niques, most notably the use of the internal mammary artery 
as a bypass conduit (36,37), have decreased the incidence of
graft failure. However, the ~jo~ty of coronary bypass 
surgeons still employ the saphenous vein as a preferred 
conduit (38), although it remains associated with a significant 
incidence ofgraft failure; in addition, there may be progres- 
sion of disease distal to grafts or in nonbypassed vessels 
(34,351. The results and risks of repeat operation are much 
less satisfactory than those associated with a primary oper- 
ation (39). In addition, the risks associated with angioplasty 
in patients with prior bypass surgery appear to be consider- 
ably less than thone c1 reoperation (40). These factors 
combine to make the choice between angioplasty and sur- 
gery complex and their roles often complementary. Thera- 
peutic decisions must take into account he possibility of 
symptom recurrence and disease progression after angio- 
plasty or bypass urgery and the consequences if repeat 
~v~cul~zation is necessa~. 
Conclushms. Patients with symptomatic single vessel dis- 
ease undergoing successful coronary angioplasty have an 
excellent prognosis. After a decade of follow-up study, late 
outcome after angioplasty compares favorably with that 
after bypass urgery. The need for subsequent repeat revas- 
cularization is more frequent a d occurs earlier after angio- 
plasty than after bypass urgery. Angiopl~ty may reduce 
the need for bypass surgery Duane long-term follow-up 
evaluation f patients in both groups, 
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